Moxifloxacin: A Review of its Clinical Potential in the Management of Community-Acquired Respiratory Tract Infections

ISSN： 0012-6667

Source： Drugs, Vol.59, Iss.1, 2000-01, pp. : 115-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Experience in Germany of Treating Community-acquired Respiratory Infections with the New 8-Methoxyfluoroquinolone, Moxifloxacin

By Landen H Möller M Tillotson GS Kubin R Höffken G

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 51-60

Field House Publishing

Access to resources Recommend Favorite

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

By Nicolau David P

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Clarithromycin extended-release in community-acquired respiratory tract infections

By Williams Kathy N Bishai William R

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2867-2876

Informa Healthcare

Access to resources Recommend Favorite

Moxifloxacin in respiratory tract infections

By Miravitlles Marc

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Ceftriaxone: An Update of its Use in the Management of Community-Acquired and Nosocomial Infections

By Lamb H.M. Ormrod D. Scott L.J. Figgitt D.P.

Drugs, Vol. 62, Iss. 7, 2002-01 ,pp. : 1041-1089

Adis International

Access to resources Recommend Favorite